KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Leukemia. 2019 Aug;33(8):2111-2115. doi: 10.1038/s41375-019-0444-6. Epub 2019 Mar 14.

¹ Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy.
² Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
³ Department of Internal Medicine and Haematology, Maggiore General Hospital, University of Trieste, Trieste, Italy.
⁴ Division of Hematology, Ferrarotto Hospital, Catania, Italy.
⁵ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
⁶ Department of Hematology/Oncology, Stanford University, Stanford, CA, USA.
⁷ Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
⁸ Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy. vgattei@cro.it.
⁹ Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy. zucchetto.soecs@cro.it.

No abstract available

Publication types